Relay Therapeutics, Inc. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
Relay Therapeutics, Inc. (RLAY) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of $56.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2022-02-24.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2022-02-24
- Relay Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2019-12-31 was $112.00K.
- Relay Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2019-09-30 was $0.00.
- Relay Therapeutics, Inc. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2019 was $56.00K.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 6 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month as first filed |
|---|---|---|---|---|---|
| 2019-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $112.00K derived: sum of 2 quarters · filed 2022-02-24 | $56.00K 10-K · filed 2022-02-24 | -$56.00K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$56.00K 10-Q · filed 2020-11-12 | |||
| 2019-06-30 | -$56.00K 10-Q · filed 2020-08-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |